Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Vivimed Labs Limited
VIVIMEDLABVivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India. Address: NCC House, (Western Wing), Hyderabad, India, 500 081
Analytics
Zielpreis von Wall Street
11 305.98 INRKGV
–Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen VIVIMEDLAB
Dividenden-Analyse VIVIMEDLAB
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
–Verlauf der Dividende VIVIMEDLAB
Bewertung der Aktie VIVIMEDLAB
Finanzen VIVIMEDLAB
Ergebnisse | 2019 | Dynamik |